The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Jak-STAT Pathways and Transcriptional Activation in Response to IFNs and Other Extracellular Signaling Proteins
Abstract
Through the study of transcriptional activation in response to interferon alpha (IFN-alpha) and interferon gamma (IFN-gamma), a previously unrecognized direct signal transduction pathway to the nucleus has been uncovered: IFN-receptor interaction at the cell surface leads to the activation of kinases of the Jak family that then phosphorylate substrate proteins called STATs (signal transducers and activators of transcription). The phosphorylated STAT proteins move to the nucleus, bind specific DNA elements, and direct transcription. Recognition of the molecules involved in the IFN-alpha and IFN-gamma pathway has led to discoveries that a number of STAT family members exist and that other polypeptide ligands also use the Jak-STAT molecules in signal transduction.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Signal transducer and activator of transcription 3 (STAT3) belongs to the family of STAT transcription factors which mediate the cellular response to a variety of cytokines and growth factors including IL-6 (6-8”
From STAT3 Contributes to the Mitogenic Response of Hepatocytes during Liver Regeneration (2002) · cites this paper as [6]
In the citing paper
“Specifically, STAT1 and IRF5 have been shown to be involved in polarization and maintenance of an M1 phenotype while STAT6, IRF4, CREB-C/EBPβ, and PPARγ are involved in polarization and maintenance of an M2 phenotype [23–30].”
From Macrophage polarization: an opportunity for improved outcomes in biomaterials and regenerative medicine (2012) · cites this paper as [23]
Citations
Cites
Zhong, Z., Wen, Z., & Darnell, J. E. (1994) · Science · doi:10.1126/science.8140422 · Cited by 2,070
Kessler, D. S., Veals, S. A., Fu, X. Y., & Levy, D. E. (1990) · Genes & Development · doi:10.1101/gad.4.10.1753 · Cited by 312
Cohen, B., Peretz, D., Vaiman, D., Benech, P., & Chebath, J. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb02958.x · Cited by 180
Research works printed but not linked: 84
- AGUET, M, MOLECULAR-CLONING AND EXPRESSION OF THE HUMAN INTERFERON-GAMMA RECEPTOR, CELL 55: 273 (1988). · DOI
- ALMENDRAL, J.M., COMPLEXITY OF THE EARLY GENETIC RESPONSE TO GROWTH-FACTORS IN MOUSE FIBROBLASTS, MOLECULAR AND CELLULAR BIOLOGY 8: 2140 (1988).
- 10.1016/0092-8674(93)90415-M · DOI
- BEADLING, C, ISOLATION OF INTERLEUKIN-2-INDUCED IMMEDIATE-EARLY GENES, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 90: 2719 (1993).
- BLANAR, M.A., TRANSCRIPTIONAL ACTIVATION OF HLA-DR-ALPHA BY INTERFERON-GAMMA REQUIRES A TRANS-ACTING PROTEIN, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 85: 4672 (1988).
- 10.1126/science.7504325 · DOI
- COLAMONICI, O.R., MULTICHAIN STRUCTURE OF THE IFN-ALPHA RECEPTOR ON HEMATOPOIETIC-CELLS, JOURNAL OF IMMUNOLOGY 148: 2126 (1992). · DOI
- DALE, T.C., OVERLAPPING SITES FOR CONSTITUTIVE AND INDUCED DNA-BINDING FACTORS INVOLVED IN INTERFERON-STIMULATED TRANSCRIPTION, EMBO JOURNAL 8: 831 (1989). · DOI
- DALE, T.C., RAPID ACTIVATION BY INTERFERON-ALPHA OF A LATENT DNA-BINDING PROTEIN PRESENT IN THE CYTOPLASM OF UNTREATED CELLS, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 86: 1203 (1989).
- 10.1126/science.1496402 · DOI
- DECKER, T, INTERACTIONS OF ALPHA-INTERFERON AND GAMMA-INTERFERON IN THE TRANSCRIPTIONAL REGULATION OF THE GENE ENCODING A GUANYLATE-BINDING PROTEIN, EMBO JOURNAL 8: 2009 (1989). · DOI
- DECKER, T, CYTOPLASMIC ACTIVATION OF GAF, AN IFN-GAMMA-REGULATED DNA-BINDING FACTOR, EMBO JOURNAL 10: 927 (1991). · DOI
- FIRMBACHKRAFT, I, TYK2, PROTOTYPE OF A NOVEL CLASS OF NONRECEPTOR TYROSINE KINASE GENES, ONCOGENE 5: 1329 (1990).
- 10.1126/science.1650499 · DOI
- 10.1093/nar/9.23.6505 · DOI
- FRIEDMAN, R.L., TRANSCRIPTIONAL AND POSTTRANSCRIPTIONAL REGULATION OF INTERFERON-INDUCED GENE-EXPRESSION IN HUMAN-CELLS, CELL 38: 745 (1984). · DOI
- 10.1016/0092-8674(92)90106-M · DOI
- FU, X.Y., ISGF3, THE TRANSCRIPTIONAL ACTIVATOR INDUCED BY INTERFERON-ALPHA, CONSISTS OF MULTIPLE INTERACTING POLYPEPTIDE-CHAINS, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 87: 8555 (1990).
- FU, X.Y., THE PROTEINS OF ISGF-3, THE INTERFERON ALPHA-INDUCED TRANSCRIPTIONAL ACTIVATOR, DEFINE A GENE FAMILY INVOLVED IN SIGNAL TRANSDUCTION, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 89: 7840 (1992).
- GARRER, M.M., NUCLEIC ACIDS RES 9: 3047 (1981). · DOI
- 10.1126/science.1898992 · DOI
- GREENBERG, M.E., NERVE GROWTH-FACTOR AND EPIDERMAL GROWTH-FACTOR INDUCE RAPID TRANSIENT CHANGES IN PROTO-ONCOGENE TRANSCRIPTION IN PC12 CELLS, JOURNAL OF BIOLOGICAL CHEMISTRY 260: 14101 (1985). · DOI
- 10.1038/311433a0 · DOI
- HARADA, H, STRUCTURALLY SIMILAR BUT FUNCTIONALLY DISTINCT FACTORS, IRF-1 AND IRF-2, BIND TO THE SAME REGULATORY ELEMENTS OF IFN AND IFN-INDUCIBLE GENES, CELL 58: 729 (1989). · DOI
- HARPUR, A.G., ONCOGENE 7: 895 (1992).
- HEMMI, S, A NOVEL MEMBER OF THE INTERFERON RECEPTOR FAMILY COMPLEMENTS FUNCTIONALITY OF THE MURINE INTERFERON-GAMMA RECEPTOR IN HUMAN-CELLS, CELL 76: 803 (1994). · DOI
- IGARASHI, K, IN-VITRO ACTIVATION OF A TRANSCRIPTION FACTOR BY GAMMA-INTERFERON REQUIRES A MEMBRANE-ASSOCIATED TYROSINE KINASE AND IS MIMICKED BY VANADATE, MOLECULAR AND CELLULAR BIOLOGY 13: 3984 (1993).
- Improta, T., Proceedings of the National Academy of Sciences of the United States of America 91: 4776 (1994).
- JOHN, J, ISOLATION AND CHARACTERIZATION OF A NEW MUTANT HUMAN CELL-LINE UNRESPONSIVE TO ALPHA-INTERFERONS AND BETA-INTERFERONS, MOLECULAR AND CELLULAR BIOLOGY 11: 4189 (1991).
- KAHN, K.D., PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 90: 6806 (1993).
- KANNO, Y, THE GENOMIC STRUCTURE OF THE MURINE ICSBP GENE REVEALS THE PRESENCE OF THE GAMMA INTERFERON-RESPONSIVE ELEMENT, TO WHICH AN ISGF3-ALPHA SUBUNIT (OR SIMILAR) MOLECULE BINDS, MOLECULAR AND CELLULAR BIOLOGY 13: 3951 (1993).
- KESSLER, D.S., 2 INTERFERON-INDUCED NUCLEAR FACTORS BIND A SINGLE PROMOTER ELEMENT IN INTERFERON-STIMULATED GENES, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 85: 8521 (1988).
- 10.1126/science.1708916 · DOI
- 10.1126/science.7694370 · DOI
- 10.1126/science.8378773 · DOI
- LARNER, A.C., TRANSCRIPTIONAL INDUCTION BY INTERFERON - NEW PROTEIN(S) DETERMINE THE EXTENT AND LENGTH OF THE INDUCTION, JOURNAL OF BIOLOGICAL CHEMISTRY 261: 453 (1986). · DOI
- LARNER, A.C., TRANSCRIPTIONAL INDUCTION OF 2 GENES IN HUMAN-CELLS BY BETA-INTERFERON, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES 81: 6733 (1984).
- LEE, T.H., ISOLATION AND CHARACTERIZATION OF 8 TUMOR NECROSIS FACTOR-INDUCED GENE-SEQUENCES FROM HUMAN FIBROBLASTS, MOLECULAR AND CELLULAR BIOLOGY 10: 1982 (1990).
- LEVY, D, NEW BIOL 2: 923 (1990).
- LEVY, D.E., SYNERGISTIC INTERACTION BETWEEN INTERFERON-ALPHA AND INTERFERON-GAMMA THROUGH INDUCED SYNTHESIS OF ONE SUBUNIT OF THE TRANSCRIPTION FACTOR ISGF3, EMBO JOURNAL 9: 1105 (1990). · DOI
- LEVY, D.E., CYTOPLASMIC ACTIVATION OF ISGF3, THE POSITIVE REGULATOR OF INTERFERON-ALPHA-STIMULATED TRANSCRIPTION, RECONSTITUTED INVITRO, GENES & DEVELOPMENT 3: 1362 (1989). · DOI
- LEVY, D.E., INTERFERON-INDUCED NUCLEAR FACTORS THAT BIND A SHARED PROMOTER ELEMENT CORRELATE WITH POSITIVE AND NEGATIVE TRANSCRIPTIONAL CONTROL, GENES & DEVELOPMENT 2: 383 (1988). · DOI
- Levy, D. E., Interferon: Principles and Medical Applications: 161 (1992).
- LEW, D.J., ALPHA-INTERFERON AND GAMMA INTERFERON STIMULATE TRANSCRIPTION OF A SINGLE GENE THROUGH DIFFERENT SIGNAL TRANSDUCTION PATHWAYS, MOLECULAR AND CELLULAR BIOLOGY 9: 5404 (1989).
- LEW, D.J., OVERLAPPING ELEMENTS IN THE GUANYLATE-BINDING PROTEIN GENE PROMOTER MEDIATE TRANSCRIPTIONAL INDUCTION BY ALPHA AND GAMMA INTERFERONS, MOLECULAR AND CELLULAR BIOLOGY 11: 182 (1991).
- LUSTER, A.D., GAMMA-INTERFERON TRANSCRIPTIONALLY REGULATES AN EARLY-RESPONSE GENE CONTAINING HOMOLOGY TO PLATELET PROTEINS, NATURE 315: 672 (1985). · DOI
- MAO, C, MUTANT HUMAN-CELLS DEFECTIVE IN INDUCTION OF MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II GENES BY INTERFERON-GAMMA, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 90: 2880 (1993).
- MCKENDRY, R, HIGH-FREQUENCY MUTAGENESIS OF HUMAN-CELLS AND CHARACTERIZATION OF A MUTANT UNRESPONSIVE TO BOTH ALPHA INTERFERON AND GAMMA INTERFERON, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 88: 11455 (1991).
- MIRKOVITCH, J, MAPPING OF RNA-POLYMERASE ON MAMMALIAN GENES IN CELLS AND NUCLEI, MOLECULAR BIOLOGY OF THE CELL 3: 1085 (1992). · DOI
- MIYAMOTO, M, REGULATED EXPRESSION OF A GENE ENCODING A NUCLEAR FACTOR, IRF-1, THAT SPECIFICALLY BINDS TO IFN-BETA-GENE REGULATORY ELEMENTS, CELL 54: 903 (1988). · DOI
- MULLER, M, COMPLEMENTATION OF A MUTANT-CELL LINE - CENTRAL ROLE OF THE 91-KDA POLYPEPTIDE OF ISGF3 IN THE INTERFERON-ALPHA AND INTERFERON-GAMMA SIGNAL-TRANSDUCTION PATHWAYS, EMBO JOURNAL 12: 4221 (1993). · DOI · Paper page
- MULLER, M, THE PROTEIN-TYROSINE KINASE JAK1 COMPLEMENTS DEFECTS IN INTERFERON-ALPHA/BETA AND INTERFERON-GAMMA SIGNAL-TRANSDUCTION, NATURE 366: 129 (1993). · DOI
- MURDOCH, G.H., EPIDERMAL GROWTH-FACTOR RAPIDLY STIMULATES PROLACTIN GENE-TRANSCRIPTION, NATURE 300: 192 (1982). · DOI
- OVERDUIN, M, 3-DIMENSIONAL SOLUTION STRUCTURE OF THE SRC HOMOLOGY-2 DOMAIN OF C-ABL, CELL 70: 697 (1992). · DOI
- PEARSE, R.N., INTERFERON-GAMMA-INDUCED TRANSCRIPTION OF THE HIGH-AFFINITY FC RECEPTOR FOR IGG REQUIRES ASSEMBLY OF A COMPLEX THAT INCLUDES THE 91-KDA SUBUNIT OF TRANSCRIPTION FACTOR ISGF3, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 90: 4314 (1993).
- PELLEGRINI, S, USE OF A SELECTABLE MARKER REGULATED BY ALPHA INTERFERON TO OBTAIN MUTATIONS IN THE SIGNALING PATHWAY, MOLECULAR AND CELLULAR BIOLOGY 9: 4605 (1989).
- PINE, R, PURIFICATION AND CLONING OF INTERFERON-STIMULATED GENE FACTOR-2 (ISGF2) - ISGF2 (IRF-1) CAN BIND TO THE PROMOTERS OF BOTH BETA-INTERFERON-STIMULATED AND INTERFERON-STIMULATED GENES BUT IS NOT A PRIMARY TRANSCRIPTIONAL ACTIVATOR OF EITHER, MOLECULAR AND CELLULAR BIOLOGY 10: 2448 (1990).
- PORTER, ACG, INTERFERON RESPONSE ELEMENT OF THE HUMAN GENE-6-16, EMBO JOURNAL 7: 85 (1988). · DOI
- REICH, N, INTERFERON-INDUCED TRANSCRIPTION OF A GENE ENCODING A 15-KDA PROTEIN DEPENDS ON AN UPSTREAM ENHANCER ELEMENT, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 84: 6394 (1987).
- 10.1126/science.8378774 · DOI
- RUTHERFORD, M.N., INTERFERON-INDUCED BINDING OF NUCLEAR FACTORS TO PROMOTER ELEMENTS OF THE 2-5A SYNTHETASE GENE, EMBO JOURNAL 7: 751 (1988). · DOI
- 10.1126/science.8397445 · DOI
- SCHINDLER, C, PROTEINS OF TRANSCRIPTION FACTOR ISGF-3 - ONE GENE ENCODES THE 91-KDA AND 84-KDA ISGF-3 PROTEINS THAT ARE ACTIVATED BY INTERFERON-ALPHA, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 89: 7836 (1992).
- 10.1126/science.1496401 · DOI · Paper page
- SHIRAYOSHI, Y, INTERFERON-INDUCED TRANSCRIPTION OF A MAJOR HISTOCOMPATIBILITY CLASS-I GENE ACCOMPANIES BINDING OF INDUCIBLE NUCLEAR FACTORS TO THE INTERFERON CONSENSUS SEQUENCE, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 85: 5884 (1988).
- 10.1016/0092-8674(94)90357-3 · DOI · Paper page
- 10.1126/science.1281555 · DOI
- 10.1126/science.7690989 · DOI · Paper page
- SHUAL, K, POLYPEPTIDE SIGNALING TO THE NUCLEUS THROUGH TYROSINE PHOSPHORYLATION OF JAK AND STAT PROTEINS, NATURE 366: 580 (1993). · DOI
- SILVENNOINEN, O, INTERFERON-INDUCED NUCLEAR SIGNALING BY JAK PROTEIN-TYROSINE KINASES, NATURE 366: 583 (1993). · DOI
- SILVENNOINEN, O, STRUCTURE OF THE MURINE JAK2 PROTEIN-TYROSINE KINASE AND ITS ROLE IN INTERLEUKIN-3 SIGNAL-TRANSDUCTION, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 90: 8429 (1993).
- 10.1126/science.8378775 · DOI
- SIMS, S. H., MOLECULAR AND CELLULAR BIOLOGY 13: 690 (1993).
- SOH, J, IDENTIFICATION AND SEQUENCE OF AN ACCESSORY FACTOR REQUIRED FOR ACTIVATION OF THE HUMAN INTERFERON-GAMMA RECEPTOR, CELL 76: 793 (1994). · DOI
- UZE, G, GENETIC TRANSFER OF A FUNCTIONAL HUMAN INTERFERON-ALPHA RECEPTOR INTO MOUSE CELLS - CLONING AND EXPRESSION OF ITS CDNA, CELL 60: 225 (1990). · DOI
- VEALS, S.A., SUBUNIT OF AN ALPHA-INTERFERON-RESPONSIVE TRANSCRIPTION FACTOR IS RELATED TO INTERFERON REGULATORY FACTOR AND MYB FAMILIES OF DNA-BINDING PROTEINS, MOLECULAR AND CELLULAR BIOLOGY 12: 3315 (1992).
- 10.1016/0092-8674(92)90105-L · DOI
- Wakao, H., EMBO J. 13: 2182 (1994). · DOI
- WATLING, D, COMPLEMENTATION BY THE PROTEIN-TYROSINE KINASE JAK2 OF A MUTANT-CELL LINE DEFECTIVE IN THE INTERFERON-GAMMA SIGNAL-TRANSDUCTION PATHWAY, NATURE 366: 166 (1993). · DOI
- WILKS, A.F., 2 NOVEL PROTEIN-TYROSINE KINASES, EACH WITH A 2ND PHOSPHOTRANSFERASE-RELATED CATALYTIC DOMAIN, DEFINE A NEW CLASS OF PROTEIN-KINASE, MOLECULAR AND CELLULAR BIOLOGY 11: 2057 (1991).
- WILKS, A.F., 2 PUTATIVE PROTEIN-TYROSINE KINASES IDENTIFIED BY APPLICATION OF THE POLYMERASE CHAIN-REACTION, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 86: 1603 (1989).
- WITTHUHN, B.A., JAK2 ASSOCIATES WITH THE ERYTHROPOIETIN RECEPTOR AND IS TYROSINE-PHOSPHORYLATED AND ACTIVATED FOLLOWING STIMULATION WITH ERYTHROPOIETIN, CELL 74: 227 (1993). · DOI
- Yamamato K. Molecular and Cellular Biology in press.
- Zhong, Z., Proceedings of the National Academy of Sciences of the United States of America 91: 4806 (1994).
Cited by
Sorted by citations
Items 1,001–1,078 of 1,078
MPHOSPH1: A Potential Therapeutic Target for Hepatocellular Carcinoma
Liu, X., Zhou, Y., Liu, X., Peng, A., Gong, H., Huang, L., Ji, K., Petersen, R. B., Zheng, L., & Huang, K. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1279 · Cited by 49
“5A–C), suggesting that STAT3 signal transduction was blocked in the process because STAT3 is activated by phosphorylation (15).”
BackgroundPegylated IFN-α regulates hepatic gene expression through transient Jak/STAT activation
Dill, M. T., Makowska, Z., Trincucci, G., Gruber, A. J., Vogt, J. E., Sinnreich, M. F., Calabrese, D., Krol, I., Lau, D., Terracciano, L., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci70408 · Cited by 47
“Type I IFNs (all IFN-αs and IFN-β) bind to the IFN-α receptor (IFNAR) and activate the receptor-associated tyrosine kinases Jak1 and Tyk2, which in turn activate signal transducer and activator of transcription 1 (STAT1) and STAT2 by phosphorylation of a tyrosine in the C-terminal domain (3).”
BackgroundDu, Z., Whitt, M., Baumann, J. M., Garner, J. M., Morton, C. L., Davidoff, A., & Pfeffer, L. (2012) · Journal of Interferon and Cytokine Research · doi:10.1089/jir.2012.0002 · Cited by 46
Souissi, I., Ladam, P., Cognet, J. A. H., Coquil, S. L., Varin‐Blank, N., Baran‐Marszak, F., Metelev, V., & Fagard, R. (2012) · Molecular Cancer · doi:10.1186/1476-4598-11-12 · Cited by 43
“Decoy oligonucleotides (dODNs) containing these consensus motifs can bind the DNA binding domains (DBD) of the TFs and block their activity. dODNs [21] and hairpin dODNs (hpdODNs) [22] have been shown to induce the death of cells in which STAT3 is activated, suggesting that the DBD is another potential target for spec…”
InfluentialHDACi: molecular mechanisms and therapeutic implications in the innate immune system
Suliman, B. A., Xu, D., & Williams, B. R. G. (2011) · Immunology and Cell Biology · doi:10.1038/icb.2011.92 · Cited by 44
“IFNs exert their functions by activating signal transducer and activator of transcription (STATs) factors to induce the Janus kinase (Jak)–STAT signaling cascade”
BackgroundGnanasambandan, K., Magis, A., & Sayeski, P. (2010) · Biochemistry · doi:10.1021/bi1014858 · Cited by 46
“Once phosphorylated by Jak2, STAT proteins dimerize and translocate into the nucleus to modulate gene transcription (29).”
Selvaggi, M., Dario, C., Normanno, G., Celano, G., & Dario, M. (2009) · Journal of Dairy Research · doi:10.1017/s0022029909990070 · Cited by 46
“STAT proteins (signal transducers and activators of transcription) are a 7-member family of latent cytoplasmic transcription factors that mediate actions of a variety of peptide hormones and cytokines within target cells (Darnell et al. 1994; Schindler & Darnell, 1995).”
BackgroundPrognostic Value of Signal Transducers and Activators of Transcription 3 in Breast Cancer
Sheen‐Chen, S., Huang, C.-C., Tang, R., Chou, F., & Eng, H.-L. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0089 · Cited by 41
JAK‐STAT signaling pathway mediates astrogliosis in brains of scrapie‐infected mice
Na, Y., Jin, J., Kim, J., Choi, E., Carp, R. I., & Kim, Y. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04769.x · Cited by 50
Zhang, X., Zhang, J., Wei, H., & Tian, Z. (2007) · Oncology Reports · doi:10.3892/or.17.6.1377 · Cited by 42
Galdiero, M., Vitiello, M., D’Isanto, M., Raieta, K., & Galdiero, E. (2006) · Cytokine · doi:10.1016/j.cyto.2006.12.003 · Cited by 46
“Several polypeptide ligands use the JAK-STAT molecules in signal transduction [12].”
BackgroundInamura, K., Matsuzaki, Y., Uematsu, N., Honda, A., Tanaka, N., & Uchida, K. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2005.06.003 · Cited by 42
Berner, M. D., Sura, M. E., Alves, B. N., & Hunter, K. (2005) · Immunology Letters · doi:10.1016/j.imlet.2004.10.020 · Cited by 46
Heidelberger, S., Zinzalla, G., Antonow, D., Essex, S., Piku Basu, B., Palmer, J., Husby, J., Jackson, P. J. M., Rahman, K. M., Wilderspin, A. F., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.05.066 · Cited by 52
Singh, D. V., & Shukla, G. (2024) · Inflammopharmacology · doi:10.1007/s10787-024-01596-8 · Cited by 53
“Afterward, Dimers enter the nucleus and attach to DNA to boost gene synthesis that responds to cytokines (Shuai et al. 1993) (Darnell et al. 1994).”
The Emerging Role of Innate Immunity in Chronic Kidney Diseases
Tang, P. C., Zhang, Y.-Y., Chan, M. K., Lam, W. W.-Y., Chung, J. Y., Kang, W., To, K., Lan, H. Y., & Tang, P. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114018 · Cited by 47
Yu, L., Liu, Z.-L., He, W., Chen, H.-F., Lai, Z.-L., Duan, Y., Cao, X.-H., Tao, J., Xu, C., Zhang, Q.-J., et al. (2020) · Cellular and molecular neurobiology · doi:10.1007/s10571-020-00812-7 · Cited by 45
Ma, J., Qi, J., Lin, S., Zhang, C., Liu, F.-Y., Xie, W., & Li, X. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-1194 · Cited by 49
“STAT3 is a core member of the STAT protein family, which consists of series of transcription factors first discovered in 1994 (19, 20).”
BackgroundGorissen, M., de Vrieze, E., Flik, G., & Huising, M. O. (2011) · Journal of Endocrinology · doi:10.1530/joe-11-0033 · Cited by 42
“Since its discovery as a regulator of interferon (IFN) responses in the immune system (Schindler et al. 1992, Darnell et al. 1994), JAK/STAT molecules were shown to represent a common signalling pathway shared by many cytokines (Shuai & Liu 2003).”
BackgroundBandyopadhyay, S. K., de la Motte, C. A., Kessler, S. P., Hascall, V., Hill, D. R., & Strong, S. A. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.080444 · Cited by 44
“The phosphorylations of 701-tyrosine and 727-serine STAT1 residues are necessary for maximum transcriptional activation of STAT1-dependent genes.(10,11,39) We provide evidence that both critical residues of STAT1 are phosphorylated on poly I:C treatment.”
BackgroundAndrianifahanana, M., Singh, A. P., Némos, C., Ponnusamy, M. P., Moniaux, N., Mehta, P. P., Varshney, G. C., & Batra, S. K. (2007) · Oncogene · doi:10.1038/sj.onc.1210532 · Cited by 54
Petersson, S., Bylander, A., Yhr, M., & Enerbäck, C. (2007) · BMC Cancer · doi:10.1186/1471-2407-7-205 · Cited by 41
“The activation of the interferon-stimulated genes (ISG) requires the activity of STAT1 transcription factor [21].”
BackgroundStat2-Dependent Regulation of MHC Class II Expression
Zhao, W., Cha, E. N., Lee, C., Park, C. Y., & Schindler, C. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.1.463 · Cited by 40
Gene Promoter Hypermethylation in Mouse Lung Tumors
Vuillemenot, B. R., Hutt, J., & Belinsky, S. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-05-0218 · Cited by 45
“CDH-13 29/45 (64) 16/25 (64) 11/16 (69) ER-a 12/45 (27) 8/25 (32) 10/16 (63)c PGR 22/36 (61) 6/25 (24)b 9/16 (56) RUNX-3 14/36 (39) 11/25 (44) 4/16 (25)x”
BackgroundPotential therapeutic targets of the JAK2/STAT3 signaling pathway in triple-negative breast cancer
Lin, L., Fei, X., Chen, L., Yao, L., & Lei, X. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1381251 · Cited by 52
“The JAK2/STAT3 signaling pathway is ubiquitously expressed in cells and vital in physiological functions (91), such as cell proliferation, differentiation, apoptosis, and immune regulation (92).”
BackgroundThe role of mitochondria in the resistance of melanoma to PD-1 inhibitors
Du, F., Yang, L.-H., Liu, J., Wang, J., Fan, L., Duangmano, S., Liu, H., Liu, M., Wang, J., Zhong, X., et al. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04200-9 · Cited by 47
Targeting type I interferons in systemic lupus erythematous
Bruera, S., Chavula, T., Madan, R., & Agarwal, S. K. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1046687 · Cited by 44
“Extensive complementary work by James Darnell, Ian Kerr and George Stark established the JAK-STAT signaling as the major pathway through which type 1 IFNs mediate their effects (Darnell et al., 1994).”
BackgroundTan, P.-H., Ji, J., Hsing, C., Tan, R., & Ji, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214394 · Cited by 55
Li, L., Fu, J., Li, J., Guo, S., Chen, Q., Zhang, Y., Liu, Z., Tan, C., Chen, H., & Wang, X. (2022) · Journal of Virology · doi:10.1128/jvi.00944-22 · Cited by 45
“The expression and phosphorylation of JAK1, TYK2, STAT1, and STAT2 were unaffected by ASFV pI215L (Fig.”
BackgroundMethodInfluentialWang, J.-H., Wang, J.-J., Li, J., Shang, H., Chen, X.-M., & Hu, X.-P. (2021) · The Plant Journal · doi:10.1111/tpj.15513 · Cited by 44
STAT3 pathway as a molecular target for resveratrol in breast cancer treatment
Kohandel, Z., Farkhondeh, T., Aschner, M., Pourbagher‐Shahri, A. M., & Samarghandian, S. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02179-1 · Cited by 51
“The involvement of STAT3 in the development, metastasis, multidrug resistance, and proliferation of cancer has been subject to extensive research [15, 16].”
BackgroundDisentangling molecular mechanisms regulating sensitization of interferon alpha signal transduction
Kok, F., Rosenblatt, M., Teusel, M., Nizharadze, T., Magalhães, V. G., Dächert, C., Maiwald, T., Vlasov, A., Wäsch, M., Tyufekchieva, S., et al. (2020) · Molecular Systems Biology · doi:10.15252/msb.20198955 · Cited by 44
Ruxolitinib synergistically enhances the anti-tumor activity of paclitaxel in human ovarian cancer
Han, E. S., Wen, W. X., Dellinger, T. H., Wu, J., Lu, S. A., Jove, R., & Yim, J. H. (2018) · Oncotarget · doi:10.18632/oncotarget.24368 · Cited by 51
“In response to cytokine stimulation, STAT3 is phosphorylated at Tyr705 by Janus family kinases (JAK) [8, 9].”
BackgroundLee, H., Shin, J., Lee, W., Ryu, B., Jang, D. S., & Lee, K. (2016) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b00609 · Cited by 48
The Interferon-Induced Mx2 Inhibits Porcine Reproductive and Respiratory Syndrome Virus Replication
Wang, H.-Y., Bai, J., Fan, B., Li, Y.-F., Zhang, Q., & Jiang, P. (2016) · Journal of Interferon and Cytokine Research · doi:10.1089/jir.2015.0077 · Cited by 44
Zhu, C., Xiao, F., Hong, J., Wang, K., Liu, X., Cai, D., Fusco, D. N., Zhao, L., Jeong, S. W., Brisac, C., et al. (2015) · Journal of Virology · doi:10.1128/jvi.00364-15 · Cited by 45
“The binding of IFN to its receptor leads to the activation of receptor-associated Janus-activated kinase 1 (JAK1) and tyrosine kinase 2 (Tyk2) (45, 46).”
BackgroundDecreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma
Wang, G. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i13.3983 · Cited by 43
Lui, G. Y. L., Kovačević, Ž., Menezes, S. V., Kalinowski, D. S., Merlot, A. M., Sahni, S., & Richardson, D. R. (2015) · Molecular Pharmacology · doi:10.1124/mol.114.096529 · Cited by 45
“…and transcription of target genes (e.g., Bcl-2, cyclin D1, and c-myc) that promote cell proliferation, survival, migration, apoptosis inhibition, and immune evasion (Darnell et al., 1994; Ihle, 1995; Sasse et al., 1997; Zushi et al., 1998; Bromberg et al., 1999;Wang et al., 2004; Xie et al., 2004).”
BackgroundAo, N., Liu, Y., Feng, H., Bian, X., Li, Z., Gu, B., Zhao, X., & Liu, Y. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000362964 · Cited by 49
Xu, X., Wen, H. L., Hu, Y., Yu, H., Zhang, Y. L., Chen, C., & Pan, X. (2014) · Journal of Molecular Histology · doi:10.1007/s10735-014-9571-6 · Cited by 51
Dynamic trafficking of STAT5 depends on an unconventional nuclear localization signal
Shin, H., & Reich, N. (2013) · Journal of Cell Science · doi:10.1242/jcs.123042 · Cited by 44
“The family of signal transducers and activators of transcription (STATs) exemplifies signaling molecules that can sense changes at the plasma membrane and subsequently redirect gene expression (Darnell et al., 1994; Levy and Darnell, 2002; Schindler et al., 2007).”
BackgroundDevelopmental differences in IFN signaling affect GATA1s-induced megakaryocyte hyperproliferation
Woo, A. J., Wieland, K., Huang, H., Akie, T. E., Piers, T., Kim, J., & Cantor, A. B. (2013) · Journal of Clinical Investigation · doi:10.1172/jci40609 · Cited by 48
“Binding of IFN-α/β to its heterodimeric receptors, IFNAR1 and IFNAR2, leads to activation of the JAK-STAT pathway, with JAK1/ TYK2 and STAT1/STAT2 being the most important contributors (35, 36).”
Interferon-α (IFNα) neurotoxicity
Fritz-French, C., & Tyor, W. R. (2012) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2012.01.001 · Cited by 46
Hikata, T., Takaishi, H., Takito, J., Hakozaki, A., Furukawa, M., Uchikawa, S., Kimura, T., Okada, Y., Matsumoto, M., Yoshimura, A., et al. (2008) · Blood · doi:10.1182/blood-2008-06-162594 · Cited by 45
Boorjian, S. A., Milowsky, M. I., Kaplan, J., Albert, M., Cobham, M. V., Coll, D. M., Mongan, N. P., Shelton, G., Petrylak, D. P., Gudas, L. J., et al. (2007) · Journal of Immunotherapy · doi:10.1097/cji.0b013e31805449a8 · Cited by 52
“Median relapse-free interval (mo) (range)* 66 (12-168) 10.”
Digesting the Role of JAK-STAT and Cytokine Signaling in Oral and Gastric Cancers
Ni, Y., Low, J. T., Silke, J., & O’Reilly, L. A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.835997 · Cited by 47
Wang, H., Hou, W., Perera, A., Bettler, C., Beach, J. R., Ding, X., Li, J., Denning, M. F., Dhanarajan, A. R., Cotler, S. J., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108765 · Cited by 47
“Although knockdown of EphA2 did not affect STAT3 mRNA expression levels in HCC cells (Figure S5A), EphA2 knockdown in HCC cells suppressed phosphorylation of STAT3 at Tyr705 (Figure 5B), which is critical for STAT3 activation (Darnell et al., 1994).”
JMJD4-demethylated RIG-I prevents hepatic steatosis and carcinogenesis
Li, Z., Zhou, Y., Jia, K., Yang, Y., Zhang, L., Wang, S., Dong, Y., Wang, M., Li, Y., Lu, S., et al. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01381-6 · Cited by 44
Tumor-associated macrophages in classical Hodgkin lymphoma: hormetic relationship to outcome
Werner, L. C., Dreyer, J. H., Hartmann, D., Barros, M. H. M., Büttner-Herold, M. J., Grittner, U., & Niedobitek, G. (2020) · Scientific Reports · doi:10.1038/s41598-020-66010-z · Cited by 48
Antiviral and Inflammatory Cellular Signaling Associated with Enterovirus 71 Infection
Jin, Y., Zhang, R., Wu, W., & Duan, G. (2018) · Viruses · doi:10.3390/v10040155 · Cited by 48
“The binding of IFN-α/β to the type I IFN receptors or IFN-γ to the type II IFN receptors results in the rapid autophosphorylation and activation of Janus-activated kinase (Jak)/signal transducer and activator of transcription (STAT) pathways [37].”
BackgroundAn Activating Mutation in STAT3 Results in Neonatal Diabetes Through Reduced Insulin Synthesis
Velayos, T., Martínez, R., Alonso, M., García‐Etxebarria, K., Aguayo, A., Camarero, C., Urrutia, I., de la Piscina, I. M., Barrio, R., Santín, I., et al. (2017) · Diabetes · doi:10.2337/db16-0867 · Cited by 48
“The Identified STAT3 Mutation Leads to Increased STAT3 Activity but Does Not Affect STAT3 Phosphorylation The transcription factor STAT3 is activated by phosphorylation at tyrosine 705, which induces dimerization, nuclear translocation, and DNA binding (21).”
BackgroundLi, Y., Zhang, Z., Liu, X., Huang, T., He, W., Shen, Y., Liu, X., Hong, K., & Cao, Q. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1913-2 · Cited by 39
“Activation by inflammatory cytokines like interleukin-6 (IL-6), IL-11, and interferon (IFN), as well as by lipopolysaccharide (LPS) induces STAT3 tyrosine-705 phosphorylation and dimer formation, cytoplasmic-to-nuclear shuttling, recognition of STAT3-specific DNA-binding elements, and transcriptional activation of tar…”
FGF2 regulates melanocytes viability through the STAT3-transactivated PAX3 transcription
Dong, L., Li, Y., Cao, J., Liu, F., Pier, E., Chen, J., Xu, Z., Chen, C., Wang, R.-A., & Cui, R. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.132 · Cited by 43
STAT3 is involved in phosphatidic acid-induced Bcl-2 expression in HeLa cells
Choi, H., Lee, J. H., Park, S., Cho, J. H., & Han, J. (2009) · Experimental & Molecular Medicine · doi:10.3858/emm.2009.41.2.012 · Cited by 43
Kim, S.-H., Oh, J., Choi, J., Jang, J.-Y., Kang, M.-W., & Lee, C.-E. (2008) · BMC Immunology · doi:10.1186/1471-2172-9-64 · Cited by 43
“The analysis of the signal pathways induced by IFN-γ in monocytic cells revealed that, in addition to the well-known Jak1/Stat1 pathways [35], IFN-γ generates strong activating signals for Akt, Erk and p38 MAPK within 15 to 60 min (Fig 4A).”
BackgroundKovaleva, M., Bußmeyer, I., Rabe, B., Grötzinger, J., Sudarman, E., Eichler, J., Conrad, U., Rose‐John, S., & Scheller, J. (2006) · Journal of Virology · doi:10.1128/jvi.00420-06 · Cited by 41
“Dimerization of gp130 leads to the activation of kinases of the JAK family and of the STAT1 and STAT3 transcriptional activators (19, 76).”
BackgroundHypericum perforatum attenuates the development of carrageenan-induced lung injury in mice
Menegazzi, M., Paola, R. D., Mazzon, E., Muià, C., Genovese, T., Crisafulli, C., Suzuki, H., & Cuzzocrea, S. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.08.034 · Cited by 43
Aricò, E., Wang, E., Tornesello, M., Tagliamonte, M., Lewis, G., Marincola, F., Buonaguro, F., & Buonaguro, L. (2005) · Journal of Translational Medicine · doi:10.1186/1479-5876-3-45 · Cited by 43
“STAT2 is activated upon the binding of type-I IFN, the major component of the innate immune system, to its receptor and participates to the formation of interferonstimulated gene factor 3 (ISGF3) complex, composed of STAT1, STAT2, and IFN regulatory factor 9, which promotes serial synthesis of selected proteins that i…”
BackgroundCao, X.-P., Yang, J.-C., Burkhardt, B. R., Gao, Z., Wong, R., Greene, S. R., Wu, J.-M., & Wolf, B. (2005) · American Journal of Physiology. Endocrinology and Metabolism · doi:10.1152/ajpendo.00113.2005 · Cited by 43
“The STAT family has numerous isoforms, and they are necessary components of cytokine receptor signaling (9).”
BackgroundNetterwald, J., Yang, S.-J., Wang, W.-J., Ghanny, S., Cody, M. J., Soteropoulos, P., Tian, B., Dunn, W., Liu, F.-Y., & Zhu, H. (2005) · Journal of Virology · doi:10.1128/jvi.79.8.5035-5046.2005 · Cited by 43
“While it is clear from this study that the two VRS1 elements in the MIEP/E are important for major IE expression and viral growth in HFF cells at a low MOI, we propose that the HCMV-initiated signal transduction pathway, which leads to the activation of ISGs, directly regulates major IE expression through the VRS1 sit…”
BackgroundInfluentialActivation of Mitogen-activated Protein Kinase Kinase (MKK) 3 and MKK6 by Type I Interferons
Li, Y., Batra, S., Sassano, A., Majchrzak, B., Levy, D. E., Gaestel, M., Fish, E. N., Davis, R. J., & Platanias, L. C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410972200 · Cited by 37
Role of prostaglandin E2 in macrophage polarization: Insights into atherosclerosis
Wang, W., Liang, M., Wang, L., Bei, W., Rong, X., Xu, J., & Guo, J. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115357 · Cited by 46
Chang, W., Luo, Q., Wu, X., Nan, Y., Zhao, P., Zhang, L., Luo, A., Jiao, W., Zhu, Q., Fu, Y., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111561 · Cited by 41
Obinata, D., Takayama, K., Takahashi, S., & Inoue, S. (2017) · Cancers · doi:10.3390/cancers9030022 · Cited by 50
An, K., Fang, L.-R., Luo, R., Wang, D., Xie, L.-L., Yang, J., Chen, H.-C., & Xiao, S.-B. (2014) · Journal of Proteome Research · doi:10.1021/pr500173p · Cited by 42
Host STAT2/type I interferon axis controls tumor growth
Yue, C., Xu, J., Estioko, M. D. T., Kotredes, K. P., Lopez-Otalora, Y., Hilliard, B. A., Baker, D. P., Gallucci, S., & Gamero, A. M. (2014) · International Journal of Cancer · doi:10.1002/ijc.29004 · Cited by 38
Zhang, H.-Y., Jin, X.-B., & Lue, T. F. (2011) · Asian Journal of Andrology · doi:10.1038/aja.2010.162 · Cited by 39
Banerjee, A. R., Kim, Y. J., & Kim, T. H. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku1018 · Cited by 39
“This element, a known component of the antiviral response (30), shared 10 out of 11 identical bases between human and mouse.”
BackgroundInfluentialIwamoto, T., Senga, T., Naito, Y., Matsuda, S., Miyake, Y., Yoshimura, A., & Hamaguchi, M. (2000) · Oncogene · doi:10.1038/sj.onc.1203829 · Cited by 36
Signalling Pathways Activated by All- trans -Retinoic Acid in Acute Promyelocytic Leukemia Cells
Kambhampati, S., Verma, A., Li, Y., Parmar, S., Sassano, A., & Platanias, L. (2004) · Leukemia & Lymphoma · doi:10.1080/10428190410001722053 · Cited by 29
Kroczynska, B., Rafidi, R. L., Majchrzak-Kita, B., Kosciuczuk, E. M., Blyth, G. T., Jemielity, J., Warminska, Z., Saleiro, D., Mehrotra, S., Arslan, A. D., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.664995 · Cited by 29
Pan, X.-Y., Wang, L., You, H.-M., Cheng, M., Yang, Y., Huang, C., & Li, J. (2021) · Laboratory Investigation · doi:10.1038/s41374-021-00531-7 · Cited by 26
“ylation and subsequent dimerization of (STAT)1 [10].”
Hui, L., Yao, Y., Wang, S., Yu, Y., Dong, N., Li, H., & Sheng, Z. (2009) · Journal of Trauma: Injury, Infection & Critical Care · doi:10.1097/ta.0b013e318164d05f · Cited by 42
“For example, interferon (IFN)- employs the JAK/STAT pathway for its signal transduction to augment the innate immune response initiated by LPS, TNF- , or IL-1, and proinflammatory effect of IL-6 is mainly mediated by STAT1/3.4,5 Thus, blockade of JAK/STAT pathway at the right time as well as in the appropriate point p…”
BackgroundInfluentialBiological Hallmarks and Emerging Strategies to Target STAT3 Signaling in Multiple Myeloma
Zhou, J., & Chng, W.-J. (2022) · Cells · doi:10.3390/cells11060941 · Cited by 22
“Janus tyrosine kinases (JAKs)-STAT pathway was originally discovered in the context of interleukin-mediated inflammatory response [15].”
BackgroundNecdin, a negative growth regulator, is a novel STAT3 target gene down-regulated in human cancer
Haviland, R., Eschrich, S., Bloom, G., Ma, Y., Minton, S., Jove, R., & Cress, W. D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024923 · Cited by 19
Oladunni, F. S., Sarkar, S., Reedy, S., Balasuriya, U. B. R., Horohov, D. W., & Chambers, T. M. (2019) · Journal of Virology · doi:10.1128/jvi.01342-19 · Cited by 18
Nagakura, I., Van Wart, A., Petravicz, J., Tropea, D., & Sur, M. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0189-14.2014 · Cited by 18
MAPK signaling during Müller glial cell development in retina explant cultures
Zhang, S. S.-M., Li, H., Huang, P., Lou, L. X., Fu, X.-Y., & Barnstable, C. J. (2010) · Journal of Ocular Biology, Diseases, and Informatics · doi:10.1007/s12177-011-9064-8 · Cited by 7
“After phosphorylation, the activated STAT proteins dimerize in the cytoplasm and then translocate to the nucleus where they can modulate transcription [20].”
Background
Metadata
- Authors
- Darnell, J. E., Kerr, L. M., & Stark, G. R.
- Affiliations
- Rockefeller University (US)
- Case Comprehensive Cancer Center (US)
- ORCID
- Stark, George R.
- Venue
- Science
- Published
- 1994-06-03
- Volume
- 264
- Issue
- 5164
- Pages
- 1415-1421
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2029275361
- Cited by
- 6,080
- References
- 85
- Citations by year
- 2026: 84 · 2025: 139 · 2024: 175 · 2023: 170 · 2022: 183 · 2021: 177 · 2020: 162 · 2019: 155 · 2018: 121 · 2017: 166 · 2016: 148 · 2015: 152 · 2014: 160 · 2013: 207 · 2012: 188
- FWCI
- 28.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Keywords
- JAK/STAT signaling, interferon-alpha, interferon-gamma, signal transduction, STAT proteins, transcriptional activation, JAK kinases, interferon receptor, nuclear translocation, DNA binding
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Cell Line, DNA-Binding Proteins, Genes, Genetic Complementation Test, Humans, Interferon-gamma, Molecular Sequence Data, Mutation, Protein-Tyrosine Kinases, Regulatory Sequences, Nucleic Acid, Transcription Factors, Signal Transduction, Transcriptional Activation, Interferon-alpha, Interferon-Stimulated Gene Factor 3, Interferon-Stimulated Gene Factor 3, gamma Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review